BioSpace News Archive

Business

Verona Pharma to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update

Verona Pharma plc announces that it will report its financial results for the fourth quarter and full year ended December 31, 2021 on Thursday, March 3, 2022 and host an investment community conference call at 9:00 a.m. EST / 2:00 p.m. GMT to discuss these financial results and provide a corporate update.

February 17, 2022
·
1 min read
Business

Oncopeptides publishes year-end report 2021

Oncopeptides AB, a biotech company focused on the development of therapies for difficult-to-treat hematological diseases, has published the year-end report 2021.

February 17, 2022
·
4 min read
Immunovia Publishes Full Year Report 2021

Immunovia has published its full year report 2021.

February 17, 2022
·
11 min read
Business

Nanomerics Expands and Moves to New Laboratories

Nanomerics Ltd., a private speciality pharmaceutical company and University College London spin out, announced that the Company had invested significantly in its operations, and moved to new laboratories and offices in North London.

February 17, 2022
·
4 min read
Business

Neumora Expands Precision Neuroscience Pipeline with Novel M4 Receptor Modulator Program Through Exclusive License Agreement with Vanderbilt University

Neumora to develop and commercialize M4-selective muscarinic receptor positive allosteric modulator program for schizophrenia and other neuropsychiatric disorders.

February 17, 2022
·
4 min read
Biotech Bay

Aridis’ Pan-Coronavirus Monoclonal Antibody Cocktail AR-701 Is Protective in COVID-19 Omicron Infected Animals

Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, announced that both of its fully human monoclonal antibodies in the AR-701 cocktail neutralized the SARS-CoV-2 Omicron variant.

February 17, 2022
·
8 min read
Business

Lyra Therapeutics Appoints Harlan W. Waksal, MD, as Executive Chairman

Lyra Therapeutics today announced the appointment of Harlan W. Waksal MD, as Executive Chairman.

February 17, 2022
·
7 min read
Drug Development

U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb’s Supplemental Biologics License Application for Breyanzi

U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb’s Supplemental Biologics License Application for Breyanzi (lisocabtagene maraleucel) as a Second-Line Therapy for Relapsed or Refractory Large B-cell Lymphoma.

February 17, 2022
·
17 min read
Business

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; LINZESS® (linaclotide) Achieves Blockbuster Status as U.S. Net Sales Exceed $1 Billion in 2021

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its fourth quarter and full year 2021 results.

February 17, 2022
·
34 min read